| Variables | n = 18 (%) | |
| Gender | Male Female | 14 (77.7%) 4 (22.3%) |
| Etiology | HCV HBV HBV + HDV NBNC | 15 (83.3%) 1 (5.5%) 1 (5.5%) 1 (5.5%) |
| Co-morbid | DM HTN IHD Hereditary spherocytosis | 4 (22.3%) 5 (27.7%) 1 (5.5%) 1 (5.5%) |
| Child Class | A B | 9 (50%) 9 (50%) |
| Esophageal varices | Absent Small Large | 5 (27.7%) 3 (16.6%) 10 (55.5%) |
| Indication | Upper GI Bleed HCV treatment | 10 (55.5%) 8 (44.5%) |
| Nature of procedure | Urgent Elective | 1 (5.5%) 17 (94.5%) |
| PVA particles (micron) | 255 - 300 355 - 500 500 - 710 Both 355 - 500 & 500 - 710 | 1 (5.5%) 6 (33.3%) 11 (61.1%) 1 (5.5%) |
| Percentage embolization volume | (mean ± SD) | 37.22 ± 7.321 |
| Length of stay in days | (Median + Range) | 02 (01 - 25) |
| Follow up in days | (Median + Range) | 304 (07 - 1126) |